<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Who Pays? ‚Äî 5 Cases in Social Innovation</title>
<style>
  @import url('https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap');

  * { margin: 0; padding: 0; box-sizing: border-box; }
  :root {
    --bg: #0a0a0f;
    --surface: #111118;
    --surface-alt: #1a1a2e;
    --surface-hover: #1e1e2a;
    --border: #1e1e2e;
    --border-alt: #2a2a4a;
    --text: #e8e8ed;
    --text-secondary: #d1d5db;
    --text-muted: #9ca3af;
    --text-dim: #6b7280;
    --accent: #5ec4b6;
    --accent-glow: rgba(94, 196, 182, 0.12);
    --green: #34d399;
    --green-glow: rgba(52, 211, 153, 0.12);
    --red: #ef4444;
    --red-glow: rgba(239, 68, 68, 0.12);
    --orange: #f59e0b;
    --orange-glow: rgba(245, 158, 11, 0.12);
    --highlight: #fbbf24;
    --purple: #a78bfa;
    --purple-glow: rgba(167, 139, 250, 0.12);
    --blue: #60a5fa;
    --blue-glow: rgba(96, 165, 250, 0.12);
  }

  [data-theme="light"] {
    --bg: #f8f6f2;
    --surface: #ffffff;
    --surface-alt: #f5f3ef;
    --surface-hover: #faf8f5;
    --border: #e5e0d8;
    --border-alt: #d5d0c8;
    --text: #2c2a26;
    --text-secondary: #4a4640;
    --text-muted: #6b6560;
    --text-dim: #8a8580;
    --accent: #1a8a7d;
    --accent-glow: rgba(26, 138, 125, 0.06);
    --green: #059669;
    --green-glow: rgba(5, 150, 105, 0.08);
    --red: #dc2626;
    --red-glow: rgba(220, 38, 38, 0.08);
    --orange: #d97706;
    --orange-glow: rgba(217, 119, 6, 0.08);
    --highlight: #b45309;
    --purple: #7c3aed;
    --purple-glow: rgba(124, 58, 237, 0.08);
    --blue: #2563eb;
    --blue-glow: rgba(37, 99, 235, 0.08);
  }

  body {
    font-family: 'Inter', -apple-system, sans-serif;
    background: var(--bg);
    color: var(--text);
    padding: 40px 24px;
    min-height: 100vh;
    transition: background 0.3s ease, color 0.3s ease;
  }

  .container { max-width: 800px; margin: 0 auto; }

  .top-bar {
    display: flex; align-items: center; justify-content: space-between;
    max-width: 800px; margin: 0 auto; padding: 0 0 16px 0;
  }
  .back-link {
    font-size: 13px; color: var(--text-muted); text-decoration: none;
    display: flex; align-items: center; gap: 6px; transition: color 0.2s;
  }
  .back-link:hover { color: var(--accent); }
  .theme-toggle {
    background: none; border: 1.5px solid var(--border-alt); border-radius: 8px;
    padding: 6px 10px; cursor: pointer; font-size: 16px; color: var(--text-muted);
    transition: border-color 0.2s, color 0.2s;
  }
  .theme-toggle:hover { border-color: var(--accent); color: var(--accent); }

  .hero { text-align: center; margin: 2rem 0 3rem; animation: fadeUp 0.6s ease-out; }
  .hero .tag {
    display: inline-block; font-size: 11px; letter-spacing: 2px; text-transform: uppercase;
    color: var(--accent); background: var(--accent-glow); padding: 6px 14px;
    border-radius: 6px; margin-bottom: 16px; font-weight: 700;
  }
  .hero h1 { font-size: 28px; font-weight: 800; margin-bottom: 8px; }
  .hero .subtitle { color: var(--text-muted); font-size: 14px; line-height: 1.6; }

  .section { margin-bottom: 2.5rem; animation: fadeUp 0.6s ease-out; }
  .section h2 {
    font-size: 18px; font-weight: 700; color: var(--accent);
    margin-bottom: 1rem; padding-bottom: 0.5rem; border-bottom: 1px solid var(--border);
  }
  .section h3 { font-size: 15px; font-weight: 700; margin: 1.25rem 0 0.5rem; }
  .section p { font-size: 14px; line-height: 1.7; color: var(--text-secondary); margin-bottom: 0.75rem; }

  .card {
    background: var(--surface); border: 1px solid var(--border); border-radius: 12px;
    padding: 1.25rem; margin-bottom: 1rem;
  }
  .card-title { font-size: 14px; font-weight: 700; margin-bottom: 0.5rem; }
  .card p { margin-bottom: 0.4rem; }

  .highlight-box {
    background: var(--accent-glow); border: 1px solid var(--accent);
    border-radius: 12px; padding: 1.25rem; margin: 1.5rem 0;
  }
  .highlight-box .label { font-size: 11px; font-weight: 700; text-transform: uppercase; letter-spacing: 1px; color: var(--accent); margin-bottom: 0.5rem; }
  .highlight-box p { font-size: 14px; line-height: 1.7; color: var(--text); }

  .warning-box {
    background: var(--orange-glow); border: 1px solid var(--orange);
    border-radius: 12px; padding: 1.25rem; margin: 1.5rem 0;
  }
  .warning-box .label { font-size: 11px; font-weight: 700; text-transform: uppercase; letter-spacing: 1px; color: var(--orange); margin-bottom: 0.5rem; }
  .warning-box p { font-size: 14px; line-height: 1.7; color: var(--text); }

  .danger-box {
    background: var(--red-glow); border: 1px solid var(--red);
    border-radius: 12px; padding: 1.25rem; margin: 1.5rem 0;
  }
  .danger-box .label { font-size: 11px; font-weight: 700; text-transform: uppercase; letter-spacing: 1px; color: var(--red); margin-bottom: 0.5rem; }
  .danger-box p { font-size: 14px; line-height: 1.7; color: var(--text); }

  .success-box {
    background: var(--green-glow); border: 1px solid var(--green);
    border-radius: 12px; padding: 1.25rem; margin: 1.5rem 0;
  }
  .success-box .label { font-size: 11px; font-weight: 700; text-transform: uppercase; letter-spacing: 1px; color: var(--green); margin-bottom: 0.5rem; }
  .success-box p { font-size: 14px; line-height: 1.7; color: var(--text); }

  .purple-box {
    background: var(--purple-glow); border: 1px solid var(--purple);
    border-radius: 12px; padding: 1.25rem; margin: 1.5rem 0;
  }
  .purple-box .label { font-size: 11px; font-weight: 700; text-transform: uppercase; letter-spacing: 1px; color: var(--purple); margin-bottom: 0.5rem; }
  .purple-box p { font-size: 14px; line-height: 1.7; color: var(--text); }

  .blue-box {
    background: var(--blue-glow); border: 1px solid var(--blue);
    border-radius: 12px; padding: 1.25rem; margin: 1.5rem 0;
  }
  .blue-box .label { font-size: 11px; font-weight: 700; text-transform: uppercase; letter-spacing: 1px; color: var(--blue); margin-bottom: 0.5rem; }
  .blue-box p { font-size: 14px; line-height: 1.7; color: var(--text); }

  /* Case cards grid */
  .case-grid {
    display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; margin: 1rem 0;
  }
  @media (max-width: 600px) { .case-grid { grid-template-columns: 1fr; } }

  .case-card {
    background: var(--surface); border: 1px solid var(--border); border-radius: 12px;
    padding: 1.25rem; transition: border-color 0.2s;
  }
  .case-card:hover { border-color: var(--accent); }
  .case-card .case-emoji { font-size: 24px; margin-bottom: 0.5rem; }
  .case-card .case-name { font-size: 15px; font-weight: 700; margin-bottom: 0.25rem; }
  .case-card .case-location { font-size: 12px; color: var(--text-muted); margin-bottom: 0.6rem; }
  .case-card .case-desc { font-size: 13px; line-height: 1.6; color: var(--text-secondary); margin-bottom: 0.6rem; }
  .case-card .case-tag {
    display: inline-block; font-size: 10px; font-weight: 700; text-transform: uppercase;
    letter-spacing: 1px; padding: 3px 8px; border-radius: 4px; margin-right: 4px;
  }
  .tag-red { background: var(--red-glow); color: var(--red); }
  .tag-green { background: var(--green-glow); color: var(--green); }
  .tag-orange { background: var(--orange-glow); color: var(--orange); }
  .tag-accent { background: var(--accent-glow); color: var(--accent); }
  .tag-purple { background: var(--purple-glow); color: var(--purple); }
  .tag-blue { background: var(--blue-glow); color: var(--blue); }

  /* Full-width case card */
  .case-card-full {
    grid-column: 1 / -1;
  }

  /* Comparison table */
  table {
    width: 100%; border-collapse: collapse; font-size: 13px; margin: 1rem 0;
  }
  th, td {
    padding: 10px 12px; text-align: left; border-bottom: 1px solid var(--border);
  }
  th { font-weight: 700; color: var(--accent); font-size: 11px; text-transform: uppercase; letter-spacing: 1px; }
  td { color: var(--text-secondary); }
  tr:hover td { background: var(--surface-hover); }

  .footer {
    margin-top: 3rem; padding-top: 1.5rem; border-top: 1px solid var(--border);
    text-align: center; font-size: 12px; color: var(--text-dim);
  }

  @keyframes fadeUp {
    from { opacity: 0; transform: translateY(12px); }
    to { opacity: 1; transform: translateY(0); }
  }
</style>
</head>
<body>

<div class="top-bar">
  <a href="../index.html" class="back-link">‚Üê Back to Study Hub</a>
  <button class="theme-toggle" onclick="toggleTheme()" title="Toggle theme">
    <span id="theme-icon">üåô</span>
  </button>
</div>

<div class="container">
  <div class="hero">
    <span class="tag">Social Innovation & Design ‚Äî Week 3</span>
    <h1>üí∏ Who Pays?</h1>
    <p class="subtitle">Five cases exploring who bears the cost of social innovation ‚Äî and what happens when business models collide with social missions.</p>
  </div>

  <!-- ==================== CASE 1: INSULIN ==================== -->
  <div class="section">
    <h2>üíâ Case 1: Insulin</h2>
    <p>In 1923, Frederick Banting sold the insulin patent to the University of Toronto for <strong>$1</strong>, declaring: <em>"Insulin does not belong to me, it belongs to the world."</em> He believed a life-saving drug should be a public good.</p>
    <p>A century later, the global insulin market is controlled by <strong>three companies</strong> ‚Äî Eli Lilly, Novo Nordisk, and Sanofi ‚Äî who together hold over 90% of market share. In the US, a vial of insulin that costs ~$5 to produce has been priced at <strong>$300+</strong>. One in four American diabetics rations their insulin due to cost.</p>

    <div class="danger-box">
      <div class="label">üî¥ Core Tension</div>
      <p><strong>Public good origins ‚Üí private monopoly outcomes.</strong> The insulin case shows how a discovery explicitly intended to be free and universal was captured by market dynamics ‚Äî patents, regulatory moats, and pricing power ‚Äî over decades. It's been a century and insulin is still unaffordable for many.</p>
    </div>

    <div class="card">
      <div class="card-title">Key Numbers</div>
      <p>‚Ä¢ Patent sold for <strong>$1</strong> (1923)</p>
      <p>‚Ä¢ Production cost per vial: <strong>~$5</strong></p>
      <p>‚Ä¢ US list price per vial: <strong>$300+</strong> (before recent caps)</p>
      <p>‚Ä¢ Market controlled by: <strong>3 firms</strong> (Eli Lilly, Novo Nordisk, Sanofi)</p>
      <p>‚Ä¢ 1 in 4 US diabetics <strong>ration insulin</strong> due to cost</p>
    </div>
  </div>

  <!-- ==================== CASE 2: BANCO COMPARTAMOS ==================== -->
  <div class="section">
    <h2>üè¶ Case 2: Banco Compartamos</h2>
    <p><strong>Compartamos</strong> began as an NGO providing microloans to low-income women in rural Mexico ‚Äî the kind of social enterprise Muhammad Yunus championed with Grameen Bank. Small loans, group lending, financial inclusion for the excluded.</p>
    <p>Then it converted to a for-profit bank. Then it <strong>IPO'd in 2007</strong>. The IPO was wildly successful for investors ‚Äî but the mechanics of that success tell a darker story.</p>

    <div class="card">
      <div class="card-title">The Numbers That Disturbed Everyone</div>
      <p>‚Ä¢ Annual interest rates on microloans: <strong>~90%</strong></p>
      <p>‚Ä¢ Return on equity (ROE): <strong>~40%</strong></p>
      <p>‚Ä¢ Borrowers: <strong>low-income women</strong> in rural Mexico</p>
      <p>‚Ä¢ IPO enriched: <strong>founders, early investors, and VCs</strong></p>
    </div>

    <div class="danger-box">
      <div class="label">‚ùå Mission Drift</div>
      <p>To deliver 40% ROE to shareholders, Compartamos had to charge rates that <strong>trapped borrowers in cycles of debt</strong>. The very people the organization was created to serve became the source of profit extraction. Muhammad Yunus publicly condemned it as a <strong>betrayal of microfinance principles</strong>.</p>
    </div>

    <div class="warning-box">
      <div class="label">‚ö†Ô∏è The Cautionary Lesson</div>
      <p>Compartamos is the textbook case of what happens when a social enterprise scales through for-profit capital without structural guardrails. <strong>When the revenue model requires extracting maximum value from your beneficiaries, profit and mission are fundamentally at odds.</strong></p>
    </div>
  </div>

  <!-- ==================== CASE 3: ONEDAY HEALTH ==================== -->
  <div class="section">
    <h2>üè• Case 3: OneDay Health</h2>
    <p>In rural Uganda, roughly <strong>5 million people</strong> live more than 5km from the nearest health facility ‚Äî what OneDay Health calls healthcare "black holes." For these communities, even basic medical care (malaria testing, wound treatment, prenatal checkups) requires a half-day journey.</p>
    <p>OneDay Health's model is radically simple: set up <strong>micro health centres</strong> embedded directly in rural communities, each staffed by a trained community health worker.</p>

    <div class="success-box">
      <div class="label">‚úÖ The Model</div>
      <p>‚Ä¢ Setup cost per clinic: <strong>$4,000</strong></p>
      <p>‚Ä¢ Patient fee per visit: <strong>$1‚Äì2</strong></p>
      <p>‚Ä¢ Centres operating: <strong>70+</strong></p>
      <p>‚Ä¢ Focus: <strong>local, asset-light, community-embedded</strong></p>
    </div>

    <p>OneDay Health doesn't try to build hospitals or scale into a national health system. It operates within the constraints of its context ‚Äî low-resource, rural, and community-driven. Each centre is designed to be <strong>sustainable at the local level</strong>, not dependent on external funding to survive.</p>

    <div class="highlight-box">
      <div class="label">üî¨ Zahra Typology: Social Bricoleur</div>
      <p>OneDay Health is the classic <strong>Social Bricoleur</strong> ‚Äî working with available resources to solve immediate, local problems. It doesn't try to change the system. It works <em>within</em> the system's gaps, one village at a time.</p>
    </div>
  </div>

  <!-- ==================== CASE 4: SWIPERX ==================== -->
  <div class="section">
    <h2>üì± Case 4: SwipeRx</h2>
    <p><strong>SwipeRx</strong> (formerly mClinica) entered Indonesia's pharmacy market through <strong>education</strong> ‚Äî a free platform where pharmacists could access continuing education and professional community. This built trust and a massive user base before SwipeRx ever tried to monetize.</p>
    <p>The platform then expanded into <strong>wholesale distribution</strong>, connecting pharmacies directly with manufacturers and cutting out middlemen. The economics work: pharmacies get cheaper drugs, SwipeRx takes a margin, and patients benefit from lower prices.</p>

    <div class="card">
      <div class="card-title">Scale & Reach</div>
      <p>‚Ä¢ <strong>120,000+</strong> pharmacy professionals on platform</p>
      <p>‚Ä¢ <strong>~10,000 pharmacies</strong> using wholesale (~30% of Indonesia)</p>
      <p>‚Ä¢ Entry strategy: <strong>education-first</strong> ‚Üí wholesale ‚Üí retail</p>
      <p>‚Ä¢ Revenue model: <strong>structurally aligned with social mission</strong></p>
    </div>

    <div class="success-box">
      <div class="label">‚úÖ Profit & Mission Aligned</div>
      <p>Every additional pharmacy on SwipeRx's wholesale platform = <strong>more revenue AND better drug access</strong>. The incentives compound in the same direction. This is the opposite of the Compartamos model ‚Äî here, scaling actually deepens social impact.</p>
    </div>

    <h3>üè™ Apotek Inofarma ‚Äî Double Social Impact</h3>
    <p>SwipeRx's retail expansion through <strong>Apotek Inofarma</strong> targets underserved peri-urban and rural areas with pharmacies led by <strong>women pharmacists</strong> ‚Äî creating two layers of impact: healthcare access AND economic empowerment.</p>
  </div>

  <!-- ==================== CASE 5: IMPULSOGOV ==================== -->
  <div class="section">
    <h2>üáßüá∑ Case 5: ImpulsoGov</h2>
    <p><strong>ImpulsoGov</strong> is a Brazilian non-profit building technology to improve public healthcare prevention. Their platform connects Electronic Medical Records (EMR) with national health targets, helping municipal governments track and improve preventive care metrics.</p>

    <div class="card">
      <div class="card-title">Scale & Model</div>
      <p>‚Ä¢ <strong>81 municipalities</strong> using the platform</p>
      <p>‚Ä¢ <strong>~1 million citizens</strong> impacted</p>
      <p>‚Ä¢ Funding: <strong>donor-funded, non-profit</strong></p>
      <p>‚Ä¢ Goal: improve public health <strong>prevention</strong>, not just treatment</p>
    </div>

    <div class="purple-box">
      <div class="label">üåç Zahra Typology: Social Engineer</div>
      <p>ImpulsoGov isn't filling a gap or building a parallel structure ‚Äî it's trying to <strong>change how the existing public health system works</strong>. By connecting data infrastructure to policy targets, it aims to shift Brazil's healthcare from reactive treatment to proactive prevention.</p>
    </div>

    <div class="warning-box">
      <div class="label">‚ö†Ô∏è The Challenge</div>
      <p><strong>Demand exceeds capacity.</strong> As a donor-funded non-profit, ImpulsoGov can't scale as fast as demand requires. More municipalities want to join than the organization can support. The funding model creates a ceiling that a for-profit structure wouldn't have ‚Äî but a for-profit structure might compromise the mission.</p>
    </div>
  </div>

  <!-- ==================== COMPARISON TABLE ==================== -->
  <div class="section">
    <h2>üìä Comparison: All Five Cases</h2>
    <div style="overflow-x: auto;">
      <table>
        <thead>
          <tr>
            <th>Case</th>
            <th>Model</th>
            <th>Who Pays?</th>
            <th>Revenue ‚Üî Mission</th>
            <th>Outcome</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>Insulin</strong></td>
            <td>Public ‚Üí Private</td>
            <td>Patients (via monopoly pricing)</td>
            <td style="color: var(--red);">Diverged</td>
            <td>Unaffordable after 100 years</td>
          </tr>
          <tr>
            <td><strong>Compartamos</strong></td>
            <td>NGO ‚Üí For-profit ‚Üí IPO</td>
            <td>Poor borrowers (~90% interest)</td>
            <td style="color: var(--red);">Diverged</td>
            <td>Mission drift, extraction</td>
          </tr>
          <tr>
            <td><strong>OneDay Health</strong></td>
            <td>Micro-clinics, $1-2/visit</td>
            <td>Patients (affordable fees)</td>
            <td style="color: var(--green);">Aligned</td>
            <td>Stable, local, sustainable</td>
          </tr>
          <tr>
            <td><strong>SwipeRx</strong></td>
            <td>Platform ‚Üí Wholesale ‚Üí Retail</td>
            <td>Transaction margins</td>
            <td style="color: var(--green);">Aligned</td>
            <td>Scaling deepens impact</td>
          </tr>
          <tr>
            <td><strong>ImpulsoGov</strong></td>
            <td>Non-profit, donor-funded</td>
            <td>Donors & grants</td>
            <td style="color: var(--accent);">Aligned (but constrained)</td>
            <td>Demand > capacity</td>
          </tr>
        </tbody>
      </table>
    </div>
  </div>

  <!-- ==================== CROSS-CASE ANALYSIS ==================== -->
  <div class="section">
    <h2>üîç Cross-Case Analysis: Zahra et al. (2009) Mapping</h2>
    <p>Zahra, Gedajlovic, Neubaum, and Shulman (2009) categorize social entrepreneurs into three types based on how they approach change. Here's how each case maps:</p>

    <div class="case-grid">
      <div class="case-card">
        <div class="case-emoji">üî¨</div>
        <div class="case-name">OneDay Health</div>
        <div class="case-location">Uganda</div>
        <div class="case-desc">Works with what's available, solves local problems, doesn't try to change the system.</div>
        <span class="case-tag tag-green">Social Bricoleur</span>
      </div>

      <div class="case-card">
        <div class="case-emoji">üèóÔ∏è</div>
        <div class="case-name">SwipeRx</div>
        <div class="case-location">Indonesia</div>
        <div class="case-desc">Built new institutional infrastructure (platform) to fill a gap that markets didn't address.</div>
        <span class="case-tag tag-accent">Social Constructionist</span>
      </div>

      <div class="case-card">
        <div class="case-emoji">‚ö†Ô∏è</div>
        <div class="case-name">Compartamos</div>
        <div class="case-location">Mexico</div>
        <div class="case-desc">Started as Constructionist building microfinance access, but IPO pressure warped the mission entirely.</div>
        <span class="case-tag tag-red">Constructionist Gone Wrong</span>
      </div>

      <div class="case-card">
        <div class="case-emoji">üåç</div>
        <div class="case-name">ImpulsoGov</div>
        <div class="case-location">Brazil</div>
        <div class="case-desc">Trying to change how Brazil's public health system works ‚Äî from reactive to preventive.</div>
        <span class="case-tag tag-purple">Social Engineer</span>
      </div>

      <div class="case-card case-card-full">
        <div class="case-emoji">üíâ</div>
        <div class="case-name">Insulin (Banting et al.)</div>
        <div class="case-location">Global</div>
        <div class="case-desc">The original inventors were Social Engineers ‚Äî they wanted to change how a life-saving drug was distributed. But the outcome became a market failure: private monopoly captured a public good.</div>
        <span class="case-tag tag-purple">Social Engineers</span>
        <span class="case-tag tag-red">‚Üí Market Failure</span>
      </div>
    </div>
  </div>

  <!-- ==================== KEY INSIGHTS ==================== -->
  <div class="section">
    <h2>üí° Key Insights</h2>

    <div class="highlight-box">
      <div class="label">üí° The Alignment Test</div>
      <p><strong>"Scaling works when the revenue model and social impact compound in the same direction. When they diverge ‚Äî that's when mission drift creeps in."</strong></p>
      <p style="margin-top: 0.5rem;">SwipeRx ‚úÖ ‚Äî every new pharmacy increases both revenue and drug access. Compartamos ‚ùå ‚Äî growth required extracting more from the people they were supposed to help. Insulin ‚ùå ‚Äî public good captured by private monopoly over time.</p>
    </div>

    <div class="blue-box">
      <div class="label">üß† Sasya's Insight</div>
      <p><strong>"Stability > scalability ‚Äî not every organisation needs to scale; some interventions should be localised."</strong></p>
      <p style="margin-top: 0.5rem;">OneDay Health works precisely <em>because</em> it doesn't try to become a national health system. It's stable, community-embedded, and replicable without centralization. The pressure to "scale or die" is a VC framework, not a universal truth for social impact.</p>
    </div>

    <div class="warning-box">
      <div class="label">‚ö†Ô∏è The Funding Trap</div>
      <p>ImpulsoGov shows the flip side: <strong>donor funding preserves mission purity but creates a capacity ceiling.</strong> Compartamos shows what happens when you remove that ceiling with for-profit capital. There's no clean answer ‚Äî only trade-offs to manage deliberately.</p>
    </div>
  </div>

  <div class="footer">
    Social Innovation & Design ¬∑ Week 3 ‚Äî Study Hub ¬∑ Built with üê± by Robin
  </div>
</div>

<script>
function toggleTheme() {
  const html = document.documentElement;
  const next = html.getAttribute('data-theme') === 'dark' ? 'light' : 'dark';
  html.setAttribute('data-theme', next);
  document.getElementById('theme-icon').textContent = next === 'dark' ? '‚òÄÔ∏è' : 'üåô';
  localStorage.setItem('theme', next);
}
(function() {
  const saved = localStorage.getItem('theme') || 'light';
  document.documentElement.setAttribute('data-theme', saved);
  document.addEventListener('DOMContentLoaded', () => {
    document.getElementById('theme-icon').textContent = saved === 'dark' ? '‚òÄÔ∏è' : 'üåô';
  });
})();
</script>
</body>
</html>
